Trends in the utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer: Results from the national cancer database

Urology

Volumn 83, Issue 1, 2014, Pages 75-80

  Zaid, Harras B ^a   Patel, Sanjay G ^a   Stimson, C J ^a   Resnick, Matthew J ^a,b   Cookson, Michael S ^a   Barocas, Daniel A ^a   Chang, Sam S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER REGISTRY; CANCER STAGING; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CYSTECTOMY; DATA BASE; DRUG USE; FEMALE; GENDER; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; RACE; RANK SUM TEST; RESPONSE VARIABLE; TRANSITIONAL CELL CARCINOMA; TREND STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; URINARY BLADDER NEOPLASMS;

EID: 84891274352     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.07.072     Document Type: Article

References (22)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. S.F. Shariat, P.I. Karakiewicz, and G.S. Palapattu et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium J Urol 176 6 Pt 1 2006 2414 2422 [discussion: 2422]
3. J.P. Stein, G. Lieskovsky, and R. Cote et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients J Clin Oncol 19 2001 666 675
4. H.B. Grossman, R.B. Natale, and C.M. Tangen et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859 866
5. Advanced Bladder Cancer Overview Collaboration Neoadjuvant chemotherapy for invasive bladder cancer Cochrane Database Syst Rev 2005 CD005246
6. Advanced Bladder Cancer Meta-analysis Collaboration Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis Lancet 361 2003 1927 1934
7. International Collaboration of Trialists, Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group), and European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group et al. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial J Clin Oncol 29 2011 2171 2177
8. M.P. Porter, M.C. Kerrigan, B.M. Donato, and S.D. Ramsey Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer Urol Oncol 29 2011 252 258
9. K.Y. Bilimoria, A.K. Stewart, D.P. Winchester, and C.Y. Ko The National Cancer Data Base: a powerful initiative to improve cancer care in the United States Ann Surg Oncol 15 2008 683 690
10. K.A. David, M.I. Milowsky, and J. Ritchey et al. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base J Urol 178 2007 451 454
11. U. Fedeli, S.A., Fedewa, and E.M. Ward Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007 J Urol 185 2011 72 78
12. P.J. Gray, S.A. Fedewa, and W.U. Shipley et al. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base Eur Urol 63 2013 823 829
13. B.E. Yuh, N. Ruel, and T.G. Wilson et al. Pooled analysis of clinical outcomes with neoadjuvant cisplatin and gemcitabine chemotherapy for muscle invasive bladder cancer J Urol 189 2013 1682 1686
14. H. von der Maase, L. Sengelov, and J.T. Roberts et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer J Clin Oncol 23 2005 4602 4608
15. H. Quan, B. Li, and C.M. Couris et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries Am J Epidemiol 173 2011 676 682
16. S.A. Boorjian, S.P. Kim, and M.K. Tollefson et al. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer J Urol 190 2013 55 60
17. P. Turker, P.J. Bostrom, and M.L. Wroclawski et al. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome BJU Int 110 2012 804 811
18. A. Bamias, E. Efstathiou, and L.A. Moulopoulos et al. The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy Ann Oncol 16 2005 307 313
19. B.K. Hollenbeck, D.C. Miller, and D. Taub et al. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older Urology 64 2004 292 297
20. S.S. Chang, J.M. Hassan, and M.S. Cookson et al. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage J Urol 170 4 Pt 1 2003 1085 1087
21. C.E. Barbieri, B. Lee, and M.S. Cookson et al. Association of procedure volume with radical cystectomy outcomes in a nationwide database J Urol 178 4 Pt 1 2007 1418 1421 [discussion: 1421-1422]
22. D.C. Miller, D.S. Murtagh, and R.S. Suh et al. Regional collaboration to improve radiographic staging practices among men with early stage prostate cancer J Urol 186 2011 844 849